PAGAN ELEONORA

Valenza, C., Zheng, Y., Milano, M., Trapani, D., Giordano, E., Guidi, L., et al. (2026). Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort Study. JOURNAL OF CLINICAL ONCOLOGY [10.1200/JCO-25-01660]. Dettaglio

Okoye, C., Finazzi, A., Pagan, E., Brunetti, E., Presta, R., Monzani, F., et al. (2025). One-Year Mortality in Hospitalized, Frail Older Adults with Atrial Fibrillation on Oral Anticoagulant Therapy: Impact of Stroke and Bleeding Events. DRUGS & AGING, 42(8), 781-789 [10.1007/s40266-025-01229-x]. Dettaglio

Lisa, A., Riccardi, F., Alessandri-Bonetti, M., Mazzocconi, L., Bottoni, M., Barbieri, B., et al. (2025). Outcomes, indications and predictive factors for complications in postmastectomy prepectoral reconstructions with polyurethane foam-coated implants. THE BREAST, 83(October 2025) [10.1016/j.breast.2025.104520]. Dettaglio

Pala, L., Merlo, F., Sala, I., Pagan, E., Oriecuia, C., Specchia, C., et al. (2025). Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 117(8), 1557-1564 [10.1093/jnci/djaf049]. Dettaglio

Conforti, F., Holtschmidt, J., Nekljudova, V., Sala, I., Pagan, E., Solbach, C., et al. (2025). Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials. THE LANCET ONCOLOGY, 26(12), 1584-1597 [10.1016/S1470-2045(25)00546-7]. Dettaglio